Connection

Ki Chung to Drug Combinations

Back to Details
This is a "connection" page, showing publications Ki Chung has written about Drug Combinations.
Ki Chung
Connection Strength
0.087
Drug Combinations
  1. Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors. Oncology. 2011; 81(2):65-72.
    View in: PubMed
    Score: 0.087
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.